Growing Families conferences in London and Dublin, March 2020
Page URL: https://www.bionews.org.uk/page_147118

NHS DNA sequencing to speed up diagnosis of critically ill children

13 January 2020
Appeared in BioNews 1030

A new form of DNA testing that has the potential to rapidly diagnose rare diseases in critically ill babies and children has been made available on the NHS.

Rapid exome sequencing more than doubles the chance of a successful diagnosis and can dramatically reduce the wait for conclusive results. Eighty babies and children in England have had the test since it was introduced in October 2019, more than half of whom received a diagnosis as a result. It is estimated that it will be used for around 700 young patients annually.

'This quick and accurate new test means rapid diagnosis and reassurance for families when they need it most and give babies and children the best chance of a healthy and happy life' said NHS England chief executive Simon Stevens. 

'This kind of genomic technology is game-changing for the NHS, and will complement our existing commitment to offer whole-genome sequencing to children with cancer and rare genetic disorders,' said health minister Matt Hancock.

Although individually rare, there are between 6000 and 8000 known rare diseases, three-quarters of which affect children. Parents of children with rare diseases have described a 'diagnostic odyssey' of numerous tests and referrals to multiple different specialists often taking several years before receiving a diagnosis. 

Whole-genome and whole-exome sequencing offer the possibility to screen for a large number of rare disease-causing variants at once, and as about 80 percent of rare diseases have a genetic component, many rare neurological, metabolic and other conditions can be identified this way. 

The introduction of the test makes England one of the first countries in the world to routinely offer whole-genome sequencing. The NHS Long Term Plan includes the rollout of the Genomic Medicine Service building on the work of the 100,000 Genomes Project. Beginning with rare diseases and cancer, the plan outlines ambitions to incorporate genomics and personalised/precision medicine across the NHS, including sequencing half-a-million genomes by 2024. 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE
20 January 2020 - by Melanie Krause 
Genomics England has announced it will partner with Illumina, a US-based manufacturing and service company providing automated DNA sequencing...
29 July 2019 - by Rachel Siden 
A new report has called for genome sequencing to be trialled alongside the nine tests that currently comprise newborn screening in the UK...
11 March 2019 - by Jemma Walker and Jo Salter 
As part of the annual Genomics Conversation Week of Action, the Progress Educational Trust teamed up with Health Education England's Genomics Education Programme for an event entitled 'Talking Genomics with Patients'...
14 January 2019 - by Grace O'Regan 
The Long Term Plan announced by the NHS this week has detailed a proposal to offer whole-genome sequencing for all children with cancer in England...
10 December 2018 - by Shaoni Bhattacharya 
The UK reached its goal of sequencing 100,000 patient genomes last week...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.